VEGFA and ovarian carcinoma: TAMs directly promote the development of metastases in ovarian cancer through the production of cytokines IL-6 (Isobe et al., 2015), vascular endothelial growth factor (VEGF) (Song et al., 2019), and transforming growth factor β (TGFβ) (Rodriguez et al., 2001), among others.